4th Annual

mRNA Conference USA 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Kok-Seong Lim

Kok-Seong Lim

Independent Consultant

Close icon
Shyam Kumar Gudey

Shyam Kumar Gudey

Independent Consultant

Kok-Seong Lim

Kok-Seong Lim

Independent Consultant

Craig Martin

Craig Martin

University of Massachusetts

GLOBAL FORUM FOR MRNA-BASED THERAPEUTICS AND DRUG DEVELOPMENT

Welcome to mRNA Conference USA 2026, where global pharmaceutical and biotech leaders join industry experts to explore breakthroughs in mRNA therapeutics for vaccines, personalized medicine, and beyond.

The event explores the role of mRNA technology in developing novel treatments, covering the full spectrum from R&D to clinical trials, large-scale manufacturing, and commercialization. It highlights advancements in RNA modification, therapeutic delivery systems, and vaccine development, and showcases the latest progress in mRNA, siRNA, and miRNA-based therapeutics.

Join us to explore next-generation mRNA therapeutics, gain valuable insights, and connect with peers to help shape the future of medicine.

key topics for

Future of mRNA-based therapeutics for infectious diseases and beyond

Explore the potential of mRNA therapeutics as a transformative new class of drugs.

Breakthrough research in mRNA, siRNA, and miRNA-based therapeutics

Gain insights into how advancements in mRNA, siRNA, and miRNA are shaping the future of therapeutic applications.

Challenges in scaling mRNA vaccines manufacturing for global distribution

Analyze advanced methods for the rapid development and large-scale distribution of vaccines in response to pandemics.

Latest advancements in mRNA formulation and delivery technologies

Discover the latest advancements in therapeutic mRNA delivery as they progress from the laboratory to patient treatment.

AI and ML-driven approaches to enhance mRNA therapeutic design

Learn how advanced AI and machine learning algorithms, combined with data analytics, are accelerating therapeutic design and revealing new insights.

Regulatory and compliance considerations in mRNA clinical development

Understand key regulatory and compliance considerations for the approval of mRNA therapeutics.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • RESEARCH

    19 Dec 2025

    A New Twist Makes mRNA Drugs More Selective
  • REGULATORY

    18 Dec 2025

    BARDA Pullback Signals New Phase for US mRNA Development
  • INNOVATION

    17 Dec 2025

    mRNA Design Enters a More Predictive Era
  • INVESTMENT

    15 Dec 2025

    Moderna Bets on Debt to Power mRNA’s Next Act

mRNA Finds a New Role in Personalised Cancer Care

Illustration of syringe targeting virus cell, symbolizing mRNA cancer vaccine research

INNOVATION

12 Dec 2025

Phase 2b melanoma data fuels interest in personalized mRNA vaccines, highlighting design agility while raising new questions about scale, cost, and broader efficacy

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Hongfeng Deng

Sanofi

Brett Hill

Arcturus Therapeutics

Daniel Dixon

TriLink BioTechnologies

Show more Speakers

Past Attendees

Sanofi

28 Capital

Mayo Clinic

Arcturus Therapeutics

Crafton Biotechnology

Tessera Therapeutics

TriLink BioTechnologies

Standard BioTools

University of Michigan

Show more Attendees

hidden text

subscribe for updates

hidden text

our sponsors

arrow icon
HPNE_Endorsed_HZ_RGBMN_Logo_kompakt_1cRothwell FiggBendBioscience Black Logo
arrow icon

related events in the series